Latest Breaking News On - Market offering program - Page 1 : comparemela.com

Seanergy Maritime Reports Record First Quarter Net Income of $10 2 Million | Hellenic Shipping News Worldwide

Seanergy Maritime Reports Record First Quarter Net Income of $10 2 Million | Hellenic Shipping News Worldwide
hellenicshippingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hellenicshippingnews.com Daily Mail and Mail on Sunday newspapers.

Red seaDjibouti generalStamatis tsantanisMarket offering programSeanergy maritime holdings corpMaritime holdings corpNet revenuesAdjusted net incomeNet lossAdjusted net lossTime charter equivalentChief executive officerRecent developmentsSeanergy maritime holdings

Star Bulk Carriers Corp Reports Net Profit of $43 7 Million for the Third Quarter of 2023, and Declares Quarterly Dividend of $0 22 Per Share

ATHENS, Greece, Nov. 13, 2023 (GLOBE NEWSWIRE) Star Bulk Carriers Corp. (the Company or Star Bulk ) (Nasdaq: SBLK), a global shipping comp.

United statesNew yorkUnited kingdomNicolas bornozisPetros pappasSimos spyrouRyan leePanamax kamsarmaxStandard international dialShare repurchase program shares outstandingEuropean unionStar bulk carriersStar bulk management incCapital link incCompany or star bulk nasdaqInternational toll

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Q2 Conference Call. [Operator Instructions] Please be advised that today s conference is being recorded.

New zealandDavid hastingsLisa caperelliMike mackKaren simsDave hastingsMarket offering programArbutus biopharma corpArbutus biopharma corporationCall transcript augustBiopharma corporationBill collierChief executive officerChief financial officerMike sofiaChief scientific officer

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript August 3, 2023 Arbutus Biopharma Corporation misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $0.12. Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Q2 Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. […]

New zealandDave hastingsDavid hastingsKaren simsBrian skorneyRoy buchananMike mackMarket offering programNational cancer institute on unsplashbill collierNational cancer instituteUnsplashbill collierMarket offeringBill collierHealthy subject single ascending doseTech stocksBest healthcare

Capital increase of 360,000 shares in Orphazyme A/S as a result of the utilization of the U S At-the-Market Offering Program

18.02.2022 - Orphazyme A/SCompany announcementNo. 06/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 18, 2022 – Orphazyme A/S (ORPHA.CO (DK); ORPH (US)) (the “Company”), a late-stage biopharmaceutical company, announces . Seite 1

Anders vadsholtArticles of associationCompany board of directorsCompany us offering programCompany articles of associationMarket offering programAmerican depositary sharesNasdaq copenhagen